Mark G. Foletta, Director at DEXCOM INC (DXCM), sold 616 shares at $562.79 ($347K) on 2021-12-01, disclosed to the SEC on 2021-12-02.
Open-market sale of $347k DXCM by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $556.89 | 41 | $23K | 6.6% |
| 2 | $558.78 | 70 | $39K | 11.3% |
| 3 | $561.85 | 78 | $44K | 12.6% |
| 4 | $562.79 | 116 | $65K | 18.8% |
| 5 | $562.79 | 116 | $65K | 18.8% |
| 6 | $564.24 | 65 |
| $37K |
| 10.6% |
| 7 | $565.51 | 87 | $49K | 14.2% |
| 8 | $567.35 | 2 | $1K | 0.3% |
| 9 | $569.54 | 41 | $23K | 6.7% |
| Total | $562.82 avg | 616 | $347K | 100% |
| Filing → |
| DXCM | SELL | 2026-06-17 | $297K | — | Filing → |
| DXCM | SELL | 2025-08-18 | $430K | — | Filing → |
| DXCM | SELL | 2025-07-17 | $468K | — | Filing → |